IPO Listed

Aktis Oncology IPO

US$318m raised

Lodged 8 Jan 2026 · NASDAQ: AKTS · US$18.00 cash per share

Advisers

Issuer
Aktis Oncology
Issuer based in
United States
Listed
14 Jan 2026
Sector
Biotech
Tags
Biotech, Radiopharmaceuticals, Oncology

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.